Topics
October 2020 | Meeting Minute
Subretinal Gene Therapy
This new technology is filled with promise.
Christina Y. Weng, MD, MBA, and Jonathan F. Russell, MD, PhD
Intraocular Tumors: A Look Into the Future
The Taylor Smith and Victor Curtin Lecture was given by Carol L. Shields, MD, at this year’s meeting.
Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD
Aspen Retinal Detachment Society Meeting Coverage: Ocular Oncology and Retinal Gene Therapy
Timothy G. Murray, MD, MBA
May 13, 2026
NeuroVision Acquires Durin Life Sciences to Expand Neurodegenerative Disease Diagnostics Platform
Study: Popular GLP-1 Drugs Linked to Certain Optic Nerve Disorders
May 12, 2026
Astellas Presents New Izervay Data Showing Reduced Risk of Losing Driving Eligibility in GA Patients
AMA Unveils New Policy Framework to Combat AI “Deepfake” Impersonation of Physicians
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar